Sign in
4

Changes in Ownership

Pelthos Therapeutics Inc. Filed Acc 0001753926-24-001570

CEO, Pres., CFO, Treas & Secty bought 12,000 shares at an average $0.91 ($10,955)

From the SEC's structured data for this filing

Trades in this filing

Francis Knuettel II · CEO, Pres., CFO, Treas & Secty

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-09-10 Purchase : show line 1 in the form +6,500 $0.89 $5,785 537,010 I
2024-09-11 Purchase : show line 2 in the form +5,500 $0.94 $5,170 542,510 I
Open-market purchases · 12,000 sh · avg $0.91 · $10,955
Loading xslF345X05/ownership.xml…